Heterogeneous expression of DNA topoisomerase IIα isoforms in tumor cell lines

Oncology Research

Volumn 9, Issue 4, 1997, Pages 193-204

  Mo, Yin Yuan ^a   Beck, William T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

CEM; Isoforms; Leukemia cells; Topoisomerase ha; Tumorigenesis

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); EPITOPE; ISOENZYME; MESSENGER RNA; RNA;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CYTOPLASM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; HUMAN; METABOLISM; MOLECULAR GENETICS; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; SERODIAGNOSIS;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; CELL COMPARTMENTATION; CELL NUCLEUS; CYTOPLASM; DNA TOPOISOMERASES, TYPE II; EPITOPES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PRECIPITIN TESTS; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0030626492     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Yang, L.; Wold, M. S.; Li, J. J.; Kelly, T. J.; Liu, L. F. Rôles of DNA topoisomerase in simian virus 40 DNA replication in vitro. Proc. Natl. Acad. Sei. USA 84:950-954; 1987.
2. Brill, S. J.; DiNArdo, S.; Voelkel-Meiman, K.; Sternglanz, R. Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA. Nature 326: 414-416;1987.
3. Nelson, W. G.; Liu, L. F.; Coffey, D. S. Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells. Nature 322:187-189; 1986.
4. Kretzschmar, M.; Meisterernst, M.; Roeder, R. G. Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II. Proc. Natl. Acad. Sei. USA 90:11508-11512; 1993.
5. Merino, A.; Madden, K. R.; Lane, W. S.; Champoux, J. J.; Reinberg, D. DNA topoisomerase I is involved in both repression and activation of transcription. Nature 365:227232; 1993.
6. Holloway, S. L. Sister chromatid separation in vivo and in vitro. Curr. Opin. Genet. Dev. 2:243-248; 1995.
7. Rose, D.; Holm, C. Meiosis-specific arrest revealed in DNA topoisomerase II mutants. Mol. Cell. Biol. 13:3445-3455; 1993.
8. D'Arpa, P.; Machlin, P. S.; Ratrie, H., Ill; Rothfield, N. F.; Cleveland, D. W.; Earnshaw, W. C. cDNA cloning of human DNA topoisomerase I: Catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc. Natl. Acad. Sei. USA 85: 2543-2547; 1988.
9. Tsai-Pflugfelder, M.; Liu, L. F.; Liu, A. A.; Tewey, K. M.; Whang-Peng, J.; Knutsen, T.; Huebner, K.; Croce, C. M.; Wang, J. C. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc. Natl. Acad. Sei. USA 85: 7177-7181; 1988.
10. Champoux, J. J. Mechanistic aspects of type-I topoisomerases. In: Cozzarelli, N. Z.; Wang, J. C., eds. DNA topology and its biological effects. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1990:217-242.
11. Osheroff, N.; Corbett, A. H.; Robinson, M. J. Mechanism of action of topoisomerase II-targeted antineoplastic drugs. Adv. Pharmacol. 29B: 105-126; 1994.
12. Jenkins, J. R.; Ayton, P.; Hickson, I. D. Isolation of cDNA clones encoding the isozyme of human topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res. 20: 5587-5592; 1992.
13. Woessner, R. D.; Drake, F. H. Proliferation- and cell cycledependent differences in expression of the 170 kD and 180 kD forms of topoisomerase II in N1H-3T3 cells. Cell Growth Differen. 2:209-214; 1991.
14. Kimura, K.; Saijo, M.; Ui, M.; Enomoto, T. Growth state and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular mass form in the M phase. J. Biol. Chem. 269:1173-1176; 1994.
15. Diersack, H.; Jensen, S.; Gromova, I.; Nielsen, I. S.; Westergaard, O.; Andersen, A. H. Active heterodimers are formed from human DNA topoisomerase II and II/3 isoforms. Proc. Natl. Acad. Sei. USA 93:8288-8293; 1996.
16. Caron, P. R.; Wang, J. C. Alignment of primary sequences of DNA topoisomerases. Adv. Pharmacol. 29B:271-297; 1994.
17. Jensen, S.; Andersen, A. H.; Kjeldsen, E.; Biersack, H.; Olsen, E. H. N.; Andersen, T. B.; Westergaard, O.; Jakobsen, B. K. Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae. Mol. Cell. Biol. 16:3866-3877; 1996.
18. Watt, P. M.; Hickson, I. D. Structure and function of type II DNA topoisomerases. Biochem. J. 303:681-695; 1994.
19. Crenshaw, D. G.; Hseih, T-S. Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophila melanogaster. II. In vivo studies. J. Biol. Chem. 268: 21335-21345; 1993.
20. Corbett, A. H.; Fernald, A. W.; Osheroff, N. Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: Evidence for a common mechanism of regulation by phosphorylation. Biochemistry 32:2090-2097; 1993.
21. Wells, N. J.; Addison, C. M; Fry, A. M.; Ganapathi, R.; Hickson, I. D. Serine 1524 is a major site of phosphorylation on human topoisomerase Ha protein in vivo and is a substrate for casein kinase II in vitro. J. Biol. Chem. 269:29746-29751; 1994.
22. Wells, N. J.; Fry, A. M.; Guano, F.; Norbury, C.; Hickson, I. D. Cell cycle phase-specific phosphorylation of human topoisomerase alpha. Evidence of a role for protein kinase C. J. Biol. Chem. 270:28357-28363; 1995.
23. Kroll, D. J.; Sullivan, D. M.; Gutierrez-Hartmann, A. Modification of DNA topoisomerase II activity via direct interaction with the cyclic adenosine-3 ',5 '-monophosphate response element-binding protein and related transcription factors. Mol. Endocrinol. 7:305-318; 1993.
24. Feldhoff, P. W.; Mirski, S. E. L.; Cole, S. P. C.; Sullivan, D. M. Altered subcellular distribution of topoisomerase II in a drug-resistant human small cell lung cancer cell line. Cancer Res. 54: 756-762; 1994.
25. Harker, G. W.; Slade, D. L.; Parr, R. L.; Holguin, M. H. Selective use of an alternative stop codon and polyadenylation signal within intron sequences in human HL-60 leukemia cells selected for resistance to mitoxantrone. Cancer Res. 55:49624971; 1995.
26. Mirski, S. E. L.; Cole, S. P. C. Cytoplasmic localization of a mutant Mr 160,000 topoisomerase II alpha is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line. Cancer Res. 55: 2129-2134; 1995.
27. Yu. Q.; Mirski, S. E. L.; Spark, K.; Cole, S. P. C. Characterization of a novel 6.2 kb topoisomerase Ha mRNA in a VP-16 selected lung cancer cell line. Proc. Am. Assoc. Cancer Res. 37:428; 1996.
28. Takano, H.; Matsumoto, Y.; Uchida, Y.; Knutsen, T. R.; Fojo, T. Acquired aberrant splicing of topoisomerase Ha: A mechanism of resistance that defines a region involved in nuclear translocation. Proc. Am. Assoc. Cancer Res. 37:433; 1996.
29. Foley, G. E.; Lazaruus, H.; Farber, S.; Uzman, B. G.; Boone, B. A.; McCarthy, R. E. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522-529; 1965.
30. Beck, W. T.; Mueller, T. J.; Tanzer, L. R. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res. 39:2070-2076; 1979.
31. Danks, M. K.; Yalowich, J. C.; Beck, W. T. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26). Cancer Res. 47:1297-1301; 1987.
32. Kusumoto, H.; Rodgers, Q. E.; Boege, F.; Raimondi, S. C.; Beck, W. T. Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II. Cancer Res. 56:2573-2583; 1996.
33. Danks, M. K.; Qiu, J.; Catapano, C. V.; Schmidt, C. A.; Beck, W. T.; Fernandes, D. J. Subcellular distribution of the a and topoisomerase 1I-DNA complexes stabilized by VM26. Biochem. Pharmocol. 48:1785-1795; 1994.
34. Ausubel, F. M.; Brent, R.; Kingston, R. E.; Moore, D. D.; Seidman, J. G.; Smith, J. A.; Struhl, K. Current protocols in molecular biology. New York: Wiley-Interscience; 1989: 15.0.1-15.8.8.
35. Berghammer, H.; Auer, B. "Easyprep": Fast and easy plasmid minipreparation for analysis of recombinant clones in E. coli. Biotechniques 14:527-528; 1993.
36. Sanger, F.; Nicklen, S.; Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sei. USA 74: 5463-5467; 1977.
37. cas associates with E-cadherin complexes. Mol. Cell. Biol. 14:4333-8342; 1994.
38. Hamanaka, R.; Kohno, K.; Seguchi. T.; Okamura, K.; Morimoto, A.; Ono, M.; Ogata, J.; Kuwano, M. Induction of low density lipoprotein receptor and a transcription factor Sp-1 by tumor necrosis factor in human microvascular endothelial cells. J. Biol. Chem. 267:13160-13165; 1992.
39. Boege, F., Andersen, A.; Jensen, S.; Zeidler, R.; Kreipe, H. Proliferation-associated nuclear antigen Ki-Sl is identical with topoisomerase Ha: Delineation of a carboxyl-terminal epitope with peptide antibodies. Am. J. Pathol. 146:1302-1308; 1995.
40. Harlow, E.; Lane, D. Antibodies: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1988: 421-470.
41. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680685; 1970.
42. Dingwall, C.; Laskey, R. A. Nuclear targeting sequences-a consensus? Trends Biochem. Sei. 16:478-481; 1991.
43. Harker, G. W.; Slade, D. L.; Parr, R. L.; Feldhoff, P. W.; Sullivan D. M.; Holguin, M. H. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemic cell line. Cancer Res. 55:1707-1716; 1995.
44. Chen, M.; Beck, W. T. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines. Oncol. Res. 7:103-111; 1995.
45. Caron, P. R.; Watt, P.; Wang, J. C. The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II. Mol. Cell. Biol. 14:3197-3207:1994.
46. Crenshaw, D. G.; Hseih, T-S. Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophila melanogaster. I. In vitro studies. J. Biol. Chem. 268: 21328-21334; 1993.
47. Watt, P. M.; Louis, E. J.; Boris, R. H.; Hickson, I. D. Sgsl: A eukaryotic homolog of E. coli RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation.. Cell 81:253-260; 1995.
48. Nakano, H.; Yamazaki, T.; Miyatake, S.; Nozaki, N.; Kikuchi, A; Saito, T. Specific interaction of topoisomerase IIβ and the CDε chain of the T cell receptor complex. J. Biol. Chem. 271:6483-6489; 1996.
49. Berger, J. M.; Gamblin, S. J.; Harrison, S. C.; Wang, J. C. Structure and mechanism of DNA topoisomerase II. Nature 379:225-232; 1996.
50. D'Arpa, P.; Desai, S. Ubiquitination of topoisomerase I in cells treated with camptothecin. Proc. Am. Assoc. Cancer Res. 37:429; 1996.
51. Nakajima, T.; Morita, K.; Ohi, N.; Arail, T.; Nozaki, N.; Kikuchi, A.; Osaka, F.; Yamao, F.; Oda, K. Degradation of topoisomerase II during adenovirus ElA-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system. J. Biol. Chem. 271:24842-24849; 1996.